TG Therapeutics posts Q2 results

|About: TG Therapeutics, Inc. (TGTX)|By:, SA News Editor

TG Therapeutics (TGTX): Q2 EPS of -$0.29 misses by $0.13.

License revenue of $38,095 beats by $8K. (PR)